11 Best Japanese Stocks to Buy Right Now
Japanese equities have held steady amid heightened volatility in global markets. The country’s main equity index, the Nikkei 225, has gained 15% year to date, dwarfing the 4% gain for the S&P 500.
Takeda Pharmaceutical Co Ltd (TAK)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arjuna Capital Farnum Brown And Adam Seitchik | 62,195 | $1,151,852 | +2% | 0.29% |
| 2. | Pzena Investment Management Richard S. Pzena | 28,360 | $525,231 | +38% | 0% |
| 3. | Leucadia National Ian Cumming And Joseph Steinberg | 22,654 | $419,552 | 0% | |
| 4. | Bayforest Capital Theodoros Tsagaris | 10,291 | $190,589 | -32% | 0.21% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,740,229 | $50,749,041 | 0.01% | |
| 2. | 1,798,398 | $33,306,334 | 3.99% | |
| 3. | 1,411,927 | $26,148,889 | 0.01% | |
| 4. | 474,207 | $8,782,315 | 0% | |
| 5. | 431,602 | $7,993,269 | 0.13% |
News See All
10 Stocks to Buy on a Pullback
Pullbacks tend to create favorable setups when they hit more than just the weakest parts of the market.
10 Best Future Stocks to Buy for the Next 5 Years
On March 25, Scott Chronert of Citi joined 'Closing Bell' on CNBC to discuss whether it is time to enter the market and if recent presidential actions have changed the market dynamic.
FDA Grants Priority Review for Takeda (TAK) and Protagonist’s Rusfertide in PV Treatment
Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the most promising stocks under $20.
12 Most Promising Stocks Under $20
On March 6, Dan Niles, founder and portfolio manager at Niles Investment Management, joined CNBC's 'Power Lunch' to provide a cautious perspective on the current market rally, warning investors not to...
Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Healthcare Stocks to Buy for 2026?
Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the best healthcare stocks to buy for 2026.
12 Best Healthcare Stocks to Buy for 2026
Artificial Intelligence has been the catalyst behind the blockbuster rally in equity markets over the past two years.
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2026 Earnings Call Transcript
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2026 Earnings Call Transcript January 29, 2026Takeda Pharmaceutical Company Limited misses on earnings expectations.
13 Best Growth Stocks Under $25 to Buy Right Now
Recently, there have been concerns around the surge of fraudulent loans and private credit quality issues in the US.
Takeda Pharmaceutical Company Limited (TAK) Advances γδ T Cell Cancer Treatments
Takeda Pharmaceutical Company Limited (NYSE:TAK), a global biopharmaceutical leader, is advancing cancer treatment through novel immuno-oncology strategies focused on the innate immune system.